SCHEMBL17675764

SCHEMBL17675764

CCS(=O)(=O)NCc1ccc2c(c1)C(Cc1cccc(F)c1)NCCC2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 2/20 0.42
KDM4E B2RXH2 2/20 0.38
MAPT P10636 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
USP2 O75604 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HSP90AA1 P07900 1/20 0.38
HSP90AB1 P08238 1/20 0.38
ALOX15 P16050 1/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
HSD17B10 Q99714 1/20 0.38
ALKBH5 Q6P6C2 1/20 0.36
GAA P10253 2/20 0.36
HTT P42858 1/20 0.36
OPRM1 P35372 1/20 0.35
HTR6 P50406 1/20 0.35
SLC22A1 O15245 1/20 0.35
PRCP P42785 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17675755 0.94 SLC6A9 (0.50) SLC6A9KDM4EMAPTMEN1KMT2A
SCHEMBL13738306 0.91 SLC6A9 (0.39) SLC6A9MEN1KMT2AALKBH5GAA
SCHEMBL13827790 0.90 SLC6A9 (0.42) SLC6A9KDM4EMAPTMEN1KMT2A
SCHEMBL13827331 0.89 SLC6A9 (0.52) SLC6A9KDM4EMAPTMEN1KMT2A
SCHEMBL13827336 0.84 SLC6A9 (0.42) SLC6A9KDM4EMAPTMEN1KMT2A
SCHEMBL17675749 0.84 SLC6A9 (0.46) SLC6A9
SCHEMBL13827788 0.83 SLC6A9 (0.51) SLC6A9KDM4EMAPTMEN1KMT2A
SCHEMBL17675754 0.83 POLB (0.40) SLC6A9MAPTKMT2AHTR6GHSR
SCHEMBL13827328 0.82 SLC6A9 (0.61) SLC6A9SLC22A1PRCPGHSRADRB2
SCHEMBL17675751 0.82 SLC6A9 (0.56) SLC6A9MEN1KMT2AALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9309200-B2 Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Deutschland GmbH & Co. KG (DE) 2016-04-12 US disclosed